investment & stocks ideas
investment & stocks ideas
Favourites   Have ideas?  Sign in / Register

Positive:   Biology ↓7.42   Gene and cell ↓3.06   Biopharma ↓2.63 «See more»   Biotechnology ↓0.05   Immunology 0.00   Disease: Eye  ↑3.73

RNA stock segment: trending tickers

ADTX ADiTx Therapeutics, Inc. - Common Stock 0.00% 0 + Immunology, RNA, Medicine
+ My List
ARWR Arrowhead Pharmaceuticals, Inc. - Common Stock -2.19% down -0.59% -1.6 + Biopharma, RNA, Medicine

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/879407/000087940726000037/0000879407-26-000037-index.htm
8-K - ARROWHEAD PHARMACEUTICALS, INC. (0000879407) (Filer)
+ My List
BNTC Benitec Biopharma Inc. - Common Stock -3.06% down -1.66% -1.4 + Biopharma, Biotechnology, RNA, Medicine, Gene and cell

Last highlighted: 10-K Sec report https://www.sec.gov/Archives/edgar/data/1808898/000119312526117604/0001193125-26-117604-index.htm
10-K/A - Benitec Biopharma Inc. (0001808898) (Filer)
+ My List
LIFE aTyr Pharma, Inc. - Common Stock -7.42% down -5.63% -1.79 + Biology, RNA, Medicine

Last highlighted: 10-K Sec report https://www.sec.gov/Archives/edgar/data/1339970/000133997026000008/0001339970-26-000008-index.htm
10-K - aTYR PHARMA INC (0001339970) (Filer)
+ My List
PRQR ProQR Therapeutics N.V. - Ordinary Shares 3.73% up 2.48% 1.25 + Medicine, Biotechnology, Disease: Eye , RNA

Last highlighted: 6-K Sec report https://www.sec.gov/Archives/edgar/data/1612940/000110465926058980/0001104659-26-058980-index.htm
6-K - ProQR Therapeutics N.V. (0001612940) (Filer)
+ My List
TWST Twist Bioscience Corporation - Common Stock -0.82% up -4.23% 3.41 + Biotechnology, RNA, Medicine

Last highlighted: 10-Q Sec report https://www.sec.gov/Archives/edgar/data/1581280/000158128026000040/0001581280-26-000040-index.htm
10-Q - Twist Bioscience Corp (0001581280) (Filer)
+ My List


We do not provide financial advice. All displayed data is the result of experiments, and a subjective assessment. All decisions that will be made based on this data are made at your own risk. Thank you for understanding.